Research Paper Volume 15, Issue 17 pp 8851—8872
Integrative analysis identifies AKAP8L as an immunological and prognostic biomarker of pan-cancer
Figure 4. Promoter methylation status of CBXs in BLCA (UALCAN). The promoter of AKAP8L was hypomethylated in (A) BLCA and (B) CHOL tissues. The promoter of AKAP8L was hypermethylated in (C) KIRP tissues. The promoter of AKAP8L was hypomethylated in (D) KIRC, (E) LIHC and (F) LUSC tissues. * p < 0.05, *** p < 0.001.